Kankaanranta H, Kauppi P, Tuomist LE, Ilmarinen P
Platforms like MeAgain centralize tracking and reminders for medication timing, meals, hydration, and symptom notes, helping users turn scattershot habits into consistent, small routines that preserve energy and reduce side effects
Tirzepatide stimulates both GLP-1 and GIP receptors, and clinical data suggests this can lead to greater average weight loss than semaglutide by itself
Turmeric/Curcumin: Known for its anti-inflammatory properties, but it also has mild blood-thinning effects
The launch of new glucagon-like peptide 1 (GLP-1) receptor agonist products, a robust product pipeline for both diabetes & obesity applications, and the high efficacy of these drugs are anticipated to propel market growth